{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:07:43Z","timestamp":1779167263839,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-030857"],"award-info":[{"award-number":["INV-030857"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-061787"],"award-info":[{"award-number":["INV-061787"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["UM1AI148689"],"award-info":[{"award-number":["UM1AI148689"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["R25AI175011"],"award-info":[{"award-number":["R25AI175011"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["R01HD119968"],"award-info":[{"award-number":["R01HD119968"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008510","name":"University of Maryland","doi-asserted-by":"publisher","award":["U01AI155300"],"award-info":[{"award-number":["U01AI155300"]}],"id":[{"id":"10.13039\/100008510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019822","name":"University of Maryland Baltimore Institute for Clinical &amp; Translational Research","doi-asserted-by":"publisher","award":["T32 TR004928"],"award-info":[{"award-number":["T32 TR004928"]}],"id":[{"id":"10.13039\/100019822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25AI175011"],"award-info":[{"award-number":["R25AI175011"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD119968"],"award-info":[{"award-number":["R01HD119968"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI148689"],"award-info":[{"award-number":["UM1AI148689"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI155300"],"award-info":[{"award-number":["U01AI155300"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032339","name":"BioNTech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128388","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:12:39Z","timestamp":1772471559000},"page":"128388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TEpiNom: A computational framework integrating population data to prioritize Plasmodium falciparum T cell epitopes"],"prefix":"10.1016","volume":"77","author":[{"given":"Alexander J.","family":"Laurenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian G.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Takala-Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew B.","family":"Laurens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128388_bb0005","series-title":"World malaria report 2024","author":"WHO","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128388_bb0010","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1515257","article-title":"Seven-Year Efficacy of RTS,S\/AS01 Malaria Vaccine among Young African Children","volume":"374","author":"Olotu","year":"2016","journal-title":"New England J. Med."},{"key":"10.1016\/j.vaccine.2026.128388_bb0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","article-title":"Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine","volume":"373","author":"Neafsey","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128388_bb0020","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial","volume":"397","author":"Datoo","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128388_bb0025","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-3024.2009.01138.x","article-title":"Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming \u2018vaccine resistant malaria\u2019","volume":"31","author":"Takala","year":"2009","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0030","doi-asserted-by":"crossref","first-page":"7506","DOI":"10.1016\/j.vaccine.2015.09.110","article-title":"Designing malaria vaccines to circumvent antigen variability","volume":"33","author":"Ouattara","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128388_bb0035","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.vaccine.2018.01.069","article-title":"RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype","volume":"36","author":"Nielsen","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128388_bb0040","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite plasmodium falciparum","volume":"419","author":"Gardner","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(96)02641-2","article-title":"Current status of the plasmodium falciparum genome project","volume":"79","author":"Dame","year":"1996","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009576","article-title":"Whole-genome analysis of Malawian plasmodium falciparum isolates identifies possible targets of allele-specific immunity to clinical malaria","volume":"17","author":"Shah","year":"2021","journal-title":"PLoS Genet"},{"key":"10.1016\/j.vaccine.2026.128388_bb0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000257","article-title":"Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development","volume":"1","author":"Takala","year":"2009","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2026.128388_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12688\/wellcomeopenres.18681.1","article-title":"Pf7: an open dataset of plasmodium falciparum genome variation in 20,000 worldwide samples","volume":"8","author":"MalariaGEN","year":"2023","journal-title":"Wellcome Open Res."},{"key":"10.1016\/j.vaccine.2026.128388_bb0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jis709","article-title":"Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications","volume":"207","author":"Ouattara","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128388_bb0070","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1038\/s41598-020-60551-z","article-title":"Microarray analyses reveal strain-specific antibody responses to plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination","volume":"10","author":"Bailey","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128388_bb0075","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/339342","article-title":"A recombinant blood-stage malaria vaccine reduces plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1\u20132b trial in Papua New Guinea","volume":"185","author":"Genton","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128388_bb0080","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2026.128388_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2026.128388_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00171","article-title":"T cell responses to viral infections - opportunities for peptide vaccination","volume":"5","author":"Rosendahl Huber","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41577-019-0158-z","article-title":"T cell-mediated immunity to malaria","volume":"19","author":"Kurup","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0100","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1128\/IAI.00570-13","article-title":"CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection","volume":"81","author":"Kimura","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0105","doi-asserted-by":"crossref","first-page":"9090","DOI":"10.1073\/pnas.1303858110","article-title":"In vivo imaging of CD8+ T cell-mediated elimination of malaria liver stages","volume":"110","author":"Cockburn","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128388_bb0110","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.4049\/jimmunol.1000106","article-title":"Cross-talk between T cells and NK cells generates rapid effector responses to plasmodium falciparum - infected erythrocytes","volume":"184","author":"Horowitz","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2026.128388_bb0115","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/eji.201344437","article-title":"T-bet modulates the antibody response and immune protection during murine malaria","volume":"44","author":"Oakley","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1089\/10799900260475713","article-title":"Impaired macrophage responses may contribute to exacerbation of blood-stage plasmodium chabaudi chabaudi malaria in Interleukin-12-deficient mice","volume":"22","author":"Bastos","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.vaccine.2026.128388_bb0125","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.4049\/jimmunol.171.8.4243","article-title":"Hemozoin increases IFN-\u03b3-inducible macrophage nitric oxide generation through extracellular signal-regulated kinase- and NF-\u03baB-dependent pathways","volume":"171","author":"Jaramillo","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2026.128388_bb0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1046\/j.1365-2567.2003.01620.x","article-title":"Signalling events involved in interferon-\u03b3-inducible macrophage nitric oxide generation","volume":"108","author":"Blanchette","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128388_bb0135","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1128\/IAI.68.8.4399-4406.2000","article-title":"Central role of endogenous gamma interferon in protective immunity against blood-stage plasmodium chabaudi AS infection","volume":"68","author":"Su","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ebiom.2017.08.030","article-title":"Follicular helper T cells are essential for the elimination of plasmodium infection","volume":"24","author":"P\u00e9rez-Mazliah","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2026.128388_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004715","article-title":"Disruption of IL-21 Signaling affects T cell-B cell interactions and abrogates protective humoral immunity to malaria","volume":"11","author":"P\u00e9rez-Mazliah","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128388_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/335167a0","article-title":"Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection","volume":"335","author":"Hughes","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0155","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1073\/pnas.86.3.958","article-title":"Nucleotide substitution at major histocompatibility complex class II loci: evidence for overdominant selection","volume":"86","author":"Hughes","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128388_bb0160","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMoa1008115","article-title":"A field trial to assess a blood-stage malaria vaccine","volume":"365","author":"Thera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128388_bb0165","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128388_bb0170","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00251-015-0875-9","article-title":"HLA supertype variation across populations: new insights into the role of natural selection in the evolution of HLA-A and HLA-B polymorphisms","volume":"67","author":"Dos Santos Francisco","year":"2015","journal-title":"Immunogenetics"},{"key":"10.1016\/j.vaccine.2026.128388_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-06704-4","article-title":"High resolution class I HLA-A, -B, and -C diversity in eastern and southern African populations","volume":"15","author":"Banjoko","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128388_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.690348","article-title":"Identification and immune assessment of T cell epitopes in five plasmodium falciparum blood stage antigens to facilitate vaccine candidate selection and optimization","volume":"12","author":"Kotraiah","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/cpim.12","article-title":"TepiTool: a pipeline for computational prediction of T cell epitope candidates","volume":"114","author":"Paul","year":"2016","journal-title":"CP Immunol."},{"key":"10.1016\/j.vaccine.2026.128388_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728936","article-title":"PopCover-2.0. Improved selection of peptide sets with optimal HLA and pathogen diversity coverage","volume":"12","author":"Nilsson","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0195","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1586\/erv.12.92","article-title":"Pre-erythrocytic malaria vaccines: identifying the targets","volume":"11","author":"Duffy","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128388_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products","volume":"5","author":"Duffy","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2026.128388_bb0205","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1365-2958.2005.05024.x","article-title":"CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts","volume":"59","author":"Kariu","year":"2006","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0020004","article-title":"Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer","volume":"2","author":"Ishino","year":"2004","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0215","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/j.1462-5822.2008.01143.x","article-title":"The plasmodium TRAP\/MIC2 family member, TRAP-like protein (TLP), is involved in tissue traversal by sporozoites","volume":"10","author":"Moreira","year":"2008","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0220","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1128\/EC.00089-08","article-title":"Functional characterization of a redundant plasmodium TRAP family invasin, TRAP-like protein, by aldolase binding and a genetic complementation test","volume":"7","author":"Heiss","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2026.128388_bb0225","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1074\/jbc.M411465200","article-title":"A surface phospholipase is involved in the migration of plasmodium sporozoites through cells","volume":"280","author":"Bhanot","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2026.128388_bb0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","article-title":"Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei","volume":"216","author":"Nussenzweig","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0235","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(00)80511-5","article-title":"TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites","volume":"90","author":"Sultan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128388_bb0240","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cell.2007.09.013","article-title":"Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite","volume":"131","author":"Singh","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2026.128388_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/305029a0","article-title":"Identification and chemical synthesis of a tandemly repeated immunogenic region of plasmodium knowlesi circumsporozoite protein","volume":"305","author":"Godson","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0250","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.chom.2011.10.012","article-title":"Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa","volume":"10","author":"Giovannini","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2026.128388_bb0255","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/j.1365-2958.2005.04801.x","article-title":"Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte","volume":"58","author":"Ishino","year":"2005","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0260","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nbt0988-1065","article-title":"Hepatitis B surface antigen as carrier matrix for the repetitive epitope of the circumsporozoite protein of Plasmodium falciparum","volume":"6","author":"Rutgers","year":"1988","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0265","doi-asserted-by":"crossref","first-page":"13004","DOI":"10.1073\/pnas.0906387106","article-title":"Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design","volume":"106","author":"VanBuskirk","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128388_bb0270","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.1107449","article-title":"Crystal structure of the malaria vaccine candidate apical membrane antigen 1","volume":"308","author":"Pizarro","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128388_bb0275","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by plasmodium falciparum sporozoites","volume":"279","author":"Silvie","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2026.128388_bb0280","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002432","article-title":"Systematic identification of plasmodium falciparum sporozoite membrane protein interactions reveals an essential role for the p24 complex in host infection","volume":"20","author":"Kn\u00f6ckel","year":"2021","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2026.128388_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03791-22","article-title":"Coimmunization with preerythrocytic antigens alongside circumsporozoite protein can enhance sterile protection against Plasmodium sporozoite infection","volume":"11","author":"Vigdorovich","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.vaccine.2026.128388_bb0290","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.molbiopara.2007.03.001","article-title":"Depletion of the plasmodium berghei thrombospondin-related sporozoite protein reveals a role in host cell entry by sporozoites","volume":"153","author":"Labaied","year":"2007","journal-title":"Mol Biochem Parasitol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0295","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4049\/jimmunol.153.1.190","article-title":"Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants","volume":"153","author":"Fidock","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0300","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1462-5822.2011.01617.x","article-title":"Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites","volume":"13","author":"Mikolajczak","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0305","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1462-5822.2008.01270.x","article-title":"Type II fatty acid synthesis is essential only for malaria parasite late liver stage development","volume":"11","author":"Vaughan","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0310","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.chom.2008.11.001","article-title":"The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites","volume":"4","author":"Yu","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2026.128388_bb0315","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2958.2008.06271.x","article-title":"Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection","volume":"69","author":"Aly","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000086","article-title":"A sporozoite asparagine-rich protein controls initiation of plasmodium liver stage development","volume":"4","author":"Silvie","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128388_bb0325","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1462-5822.2009.01333.x","article-title":"LISP1 is important for the egress of plasmodium berghei parasites from liver cells","volume":"11","author":"Ishino","year":"2009","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0330","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/j.1365-2958.2009.07034.x","article-title":"Plasmodium pyruvate dehydrogenase activity is only essential for the parasite's progression from liver infection to blood infection","volume":"75","author":"Pei","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0335","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1074\/jbc.M109.070367","article-title":"Role of Plasmodium berghei cGMP-dependent protein kinase in late liver stage development","volume":"285","author":"Falae","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2026.128388_bb0340","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1365-2958.2011.07787.x","article-title":"Inactivation of a plasmodium apicoplast protein attenuates formation of liver merozoites","volume":"81","author":"Haussig","year":"2011","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0345","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1073\/pnas.0408442102","article-title":"Plasmodium liver stage developmental arrest by depletion of a protein at the parasite\u2013host interface","volume":"102","author":"Mueller","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128388_bb0350","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","article-title":"Genetically modified Plasmodium parasites as a protective experimental malaria vaccine","volume":"433","author":"Mueller","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0355","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/IAI.05861-11","article-title":"Plasmodium yoelii macrophage migration inhibitory factor is necessary for efficient liver-stage development","volume":"80","author":"Miller","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002197","article-title":"Plasmodium protease ROM1 is important for proper formation of the Parasitophorous vacuole","volume":"7","author":"Vera","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128388_bb0365","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-63611-6","article-title":"Antibodies against a short region of PfRipr inhibit plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A","volume":"10","author":"Nagaoka","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128388_bb0370","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pt.2020.04.003","article-title":"The RH5-CyRPA-Ripr complex as a malaria vaccine target","volume":"36","author":"Ragotte","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0375","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/71595","article-title":"Functional conservation of the malaria vaccine antigen MSP-119across distantly related plasmodium species","volume":"6","author":"O\u2019Donnell","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2026.128388_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00067-18","article-title":"Plasmodium falciparum MSP3 exists in a complex on the merozoite surface and generates antibody response during natural infection","volume":"86","author":"Deshmukh","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0385","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1016\/j.vaccine.2006.06.081","article-title":"Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of plasmodium falciparum in a phase 1 malaria vaccine trial","volume":"25","author":"Hermsen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128388_bb0390","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1073\/pnas.1104050108","article-title":"Evidence for erythrocyte-binding antigen 175 as a component of a ligand-blocking blood-stage malaria vaccine","volume":"108","author":"Jiang","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128388_bb0395","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.parint.2008.09.005","article-title":"Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in plasmodium falciparum merozoites","volume":"58","author":"Cao","year":"2009","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2026.128388_bb0400","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1254417","article-title":"Antibodies to PfSEA-1 block parasite egress from RBCs and protect against malaria infection","volume":"344","author":"Raj","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128388_bb0405","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1038\/s41598-023-30975-4","article-title":"Analysis of sequence diversity in plasmodium falciparum glutamic acid-rich protein (PfGARP), an asexual blood stage vaccine candidate","volume":"13","author":"Rojrung","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128388_bb0410","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41564-020-00858-9","article-title":"Structural basis for placental malaria mediated by plasmodium falciparum VAR2CSA","volume":"6","author":"Ma","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01924-3","article-title":"Molecular definition of multiple sites of antibody inhibition of malaria transmission-blocking vaccine antigen Pfs25","volume":"8","author":"Scally","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0420","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-020-01123-9","article-title":"Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48\/45 proteins","volume":"3","author":"Singh","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0425","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1235264","article-title":"The human malaria parasite Pfs47 gene mediates evasion of the mosquito immune system","volume":"340","author":"Molina-Cruz","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2026.128388_bb0430","article-title":"The UCSC genome browser database: 2025 update","author":"Perez","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128388_bb0435","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz1029","article-title":"Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools","author":"Gonzalez-Galarza","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128388_bb0440","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-0039.2001.057002128.x","article-title":"HLA class I in three west African ethnic groups: genetic distances from sub-Saharan and Caucasoid populations: HLA class I in African ethnic groups","volume":"57","author":"Modiano","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2026.128388_bb0445","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1399-0039.2008.01192.x","article-title":"HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster","volume":"73","author":"Kijak","year":"2009","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.vaccine.2026.128388_bb0450","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1093\/bioinformatics\/bts565","article-title":"CD-HIT: accelerated for clustering the next-generation sequencing data","volume":"28","author":"Fu","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128388_bb0455","series-title":"The Python language reference","author":"Rossum","year":"2010"},{"key":"10.1016\/j.vaccine.2026.128388_bb0460","series-title":"pandas-dev\/pandas: Pandas","author":"The pandas development team","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128388_bb0465","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0470","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.vaccine.2026.128388_bb0475","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1016\/j.vaccine.2015.09.061","article-title":"RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap","volume":"33","author":"Kaslow","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128388_bb0480","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1172\/JCI44423","article-title":"Advances and challenges in malaria vaccine development","volume":"120","author":"Crompton","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2026.128388_bb0485","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/334258a0","article-title":"Cytotoxic T cells specific for the circumsporozoite protein of plasmodium falciparum","volume":"334","author":"Kumar","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0490","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/336778a0","article-title":"A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules","volume":"336","author":"Sinigaglia","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2026.128388_bb0495","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01008","article-title":"RTS,S\/AS01E malaria vaccine induces memory and polyfunctional T cell responses in a pediatric African phase III trial","volume":"8","author":"Moncunill","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128388_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025786","article-title":"Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S\/AS01E and Protection against P falciparum Clinical Malaria","volume":"6","author":"Olotu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128388_bb0505","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1086\/600120","article-title":"Randomized, double-blind, phase 2a trial of Falciparum malaria vaccines RTS,S\/AS01B and RTS,S\/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection","volume":"200","author":"Kester","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128388_bb0510","doi-asserted-by":"crossref","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","article-title":"The immune epitope database (IEDB): 2024 update","volume":"53","author":"Vita","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2026.128388_bb0520","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061395","article-title":"The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection","volume":"8","author":"White","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128388_bb0525","doi-asserted-by":"crossref","DOI":"10.3201\/eid3006.230975","article-title":"Follow-up study of effectiveness of 23-valent pneumococcal polysaccharide vaccine against all-type and serotype-specific invasive pneumococcal disease, Denmark","volume":"30","author":"Nielsen","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128388_bb0530","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current Progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem Rev"},{"key":"10.1016\/j.vaccine.2026.128388_bb0535","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/QAD.0b013e32835e1616","article-title":"Hiv escape mutations occur preferentially at HLA-binding sites of CD8 T-cell epitopes","volume":"27","author":"Bronke","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2026.128388_bb0540","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/324320","article-title":"Strong HLA class I\u2013restricted T cell responses in dengue hemorrhagic fever: a double-edged sword?","volume":"184","author":"Loke","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2026.128388_bb0545","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23212-x","article-title":"CD8+ T cell landscape in indigenous and non-indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph","volume":"12","author":"Hensen","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128388_bb0550","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071610","article-title":"Computational and experimental validation of B and T-cell epitopes of the in vivo immune response to a novel malarial antigen","volume":"8","author":"Bergmann-Leitner","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2026.128388_bb0555","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/iid3.283","article-title":"Identification and characterization of protective CD8+ T-epitopes in a malaria vaccine candidate SLTRiP","volume":"8","author":"Quadiri","year":"2020","journal-title":"Immunity Inflam & Disease"},{"key":"10.1016\/j.vaccine.2026.128388_bb0560","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-016-1098-8","article-title":"Measurement of ex vivo ELISpot interferon-gamma recall responses to plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria","volume":"15","author":"Ganeshan","year":"2016","journal-title":"Malar J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26001969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T04:16:27Z","timestamp":1779164187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26001969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":111,"alternative-id":["S0264410X26001969"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128388","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TEpiNom: A computational framework integrating population data to prioritize Plasmodium falciparum T cell epitopes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128388"}}